Clinical Reviews in Allergy & Immunology

, Volume 42, Issue 3, pp 322–330

The Clinical Significance of 25OH-Vitamin D Status in Celiac Disease

  • Aaron Lerner
  • Yinon Shapira
  • Nancy Agmon-Levin
  • Avi Pacht
  • Dana Ben-Ami Shor
  • Hoyos Marcus López
  • Maria Sanchez-Castanon
  • Yehuda Shoenfeld
Article

Abstract

Reduced bone mineral density is frequently found especially in adult celiac disease (CD) and dietary guidelines favor vitamin D supplementation in adults and children with CD. Vitamin D serum levels were investigated in CD populations in order to challenge its routine supplementation. Israeli (61), Spanish (59), CD children (groups 1 and 5, respectively) were compared to children with nonspecific abdominal pain (56), their parents (84) and Spanish adult CD patients (22) (group 2, 3, 4, respectively). 25(OH)-vitamin D was checked by LIAISON chemiluminescent immunoassays. Groups 5 and 1 had the highest levels compared to groups 4 and 3 with the lowest levels. The levels in groups 1 and 2 were comparable. Concerning 25(OH)-vitamin D sera levels, only the difference between group 5 and 4 was statistically significant (30.3 ± 12.3 and 20.2 ± 10.5 ng/ml, respectively p = 0.003). When vitamin D was splitted above and below 20 ng/ml level, 54.5% of Spanish adult CD had vitamin D deficiency compared to 16.9% of the local CD children (p = 0.001). 29.6% of group 2 had deficient levels compared to their parents with 50% (p = 0.019). In conclusion, Vitamin D sera levels negatively correlate with age. Thus, mainly adult CD population should be assessed for vitamin D levels and supplemented accordingly.

Keywords

Celiac disease Vitamin D Children Adults Autoimmunity Israel Spain 

References

  1. 1.
    Lerner A, Blank M, Shoenfeld Y (1996) Celiac disease and autoimmunity. Isr J Med Sci 32:33–36PubMedGoogle Scholar
  2. 2.
    Reif S, Lerner A (2004) Celiac disease and infection. In: infections and Autoimmunity. Shoenfeld, Y. and Rose, N. (Eds) Elsevier B.V. pp.689–692.Google Scholar
  3. 3.
    Reif S, Lerner A (2004) Tissue transglutaminase—the key player in celiac disease: a review. Autoimm Rev 3:40–45CrossRefGoogle Scholar
  4. 4.
    Shamir R, Eliakim R, Lahat N, Sobel E, Lerner A (2002) ELISA assay of anti endomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti endomysial antibodies and tissue transglutaminase antibodies. Isr Med Assoc J 4:594–596PubMedGoogle Scholar
  5. 5.
    Rozenberg O, Lerner A, Pacht A, Grinberg M, Reginashvili D, Henig C, Barak M (2010) A novel algorithm for childhood celiac disease serological diagnosis based upon intestinal biopsies. Crit Rev Allerg Immunol (in press)Google Scholar
  6. 6.
    Lerner A (2010) New therapeutic strategies for celiac disease. Autoimmun Rev 9:144–147PubMedCrossRefGoogle Scholar
  7. 7.
    Lerner A (1994) Factors affecting the clinical presentation and time diagnosis of celiac disease: the Jerusalem and the West Bank-Gaza experience (editorial). Isr J Med Sci 30:294–295PubMedGoogle Scholar
  8. 8.
    Branski D, Ashkenazy A, Frier S, Lerner A et al (1992) Extra intestinal manifestation and associated disorders of celiac disease. In: Branski D, Rozen P, Kaganoff MF (eds) Gluten-sensitive enteropathy from gastrointest res. Karger, Basel, pp 164–175Google Scholar
  9. 9.
    Zelnik N, Pacht A, Obeid R, Lerner A (2004) Range of neurological disorders in patients with celiac disease. Pediatrics 113:1672–1676PubMedCrossRefGoogle Scholar
  10. 10.
    Lerner A, Makhoul B, Eliakim (2010) Neurological manifestations of celiac disease in children and adults. Eur Neurolog J (in press)Google Scholar
  11. 11.
    Capriles VD, Martini LA, Arêas JA (2009) Metabolic osteopathy in celiac disease: importance of a gluten-free diet. Nutr Rev 67:599–606PubMedCrossRefGoogle Scholar
  12. 12.
    Zanchi C, Di Leo G, Ronfani L, Martelossi S, Not T, Ventura A (2008) Bone metabolism in celiac disease. J Pediatr 153:262–265PubMedCrossRefGoogle Scholar
  13. 13.
    Bianchi ML, Bardella MT (2008) Bone in celiac disease. Osteoporos Int 19:1705–1716PubMedCrossRefGoogle Scholar
  14. 14.
    Scott EM, Gaywood I, Scott BB (2000) Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 46(Suppl 1):1–8CrossRefGoogle Scholar
  15. 15.
    Turner J, Pellerin G, Mager D (2009) Prevalence of metabolic bone disease in children with celiac disease is independent of symptoms at diagnosis. J Pediatr Gastroenterol Nutr 49:589–593PubMedCrossRefGoogle Scholar
  16. 16.
    Lewis NR, Scott BB (2005) Should patients with coeliac disease have their bone mineral density measured? Eur J Gastroenterol Hepatol 17:1065–1070PubMedCrossRefGoogle Scholar
  17. 17.
    Mora S (2008) Celiac disease in children: impact on bone health. Rev Endocr Metab Disord 9:123–130PubMedCrossRefGoogle Scholar
  18. 18.
    Olmos M, Antelo M, Vazquez H, Smecuol E, Mauriño E, Bai JC (2008) Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 40:46–53PubMedCrossRefGoogle Scholar
  19. 19.
    Shoenfeld N, Amital H, Shoenfeld Y (2009) The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 5:99–105PubMedCrossRefGoogle Scholar
  20. 20.
    Albert PJ, Proal AD, Marshall TG (2009) Vitamin D: the alternative hypothesis. Autoimmun Rev 8:639–644PubMedCrossRefGoogle Scholar
  21. 21.
    Toubi E, Shoenfeld S (2010) The role of vitamin D in regulating immune responses. IMAJ 12:174–175PubMedGoogle Scholar
  22. 22.
    Pappa H, Gordon C, Saslowsky T et al (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118:1950–1961PubMedCrossRefGoogle Scholar
  23. 23.
    Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin-D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687–1692PubMedCrossRefGoogle Scholar
  24. 24.
    Aguado P, del Campo M, Garces M et al (2000) Low vitamin-D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int 11:739–744PubMedCrossRefGoogle Scholar
  25. 25.
    Kamen D, Cooper G, Bouali H et al (2006) Vitamin-D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117PubMedCrossRefGoogle Scholar
  26. 26.
    Di Cesar D, Ploutz-Snyder R, Weinstock R, Moses A (2006) Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diab Care 29:174CrossRefGoogle Scholar
  27. 27.
    Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin-D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142PubMedCrossRefGoogle Scholar
  28. 28.
    Orbach H, Zandman-Goddard G, Amital H, Barak V et al (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin-D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 1109:385–400PubMedCrossRefGoogle Scholar
  29. 29.
    Munger K, Levin L, Hollis B, Howard N, Ascherio A (2006) Serum 25-hydroxyvitamin-D levels and risk of multiple sclerosis. JAMA 296:2832–2838PubMedCrossRefGoogle Scholar
  30. 30.
    Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin N Am 39:365–379CrossRefGoogle Scholar
  31. 31.
    Pelajo CF, Lopez-Benitez JM, Miller LC (2010) Vitamin D and autoimmune rheumatologic disorders. Autoimmune Rev 9:507–510CrossRefGoogle Scholar
  32. 32.
    Shapira Y, Agmon-levin N, Shoenfeld Y (2010) Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin Rev Allerg Immunol 38:169–177CrossRefGoogle Scholar
  33. 33.
    Holick MF (2010) Vitamin D: extraskeletal health. Endocrinol Metab Clin N Am 39:381–400CrossRefGoogle Scholar
  34. 34.
    Chen S, Sims GP, Chen X et al (2007) Modulatory effects of 1, 25-dihydroxyvitamin-D3 on human B cell differentiation. J Immunol 179:1634–1647PubMedGoogle Scholar
  35. 35.
    van Etten E, Mathieu C (2005) Immunoregulation by 1, 25-dihydroxyvitamin-D3: basic concepts. J Steroid Biochem Mol Biol 97:93–101PubMedCrossRefGoogle Scholar
  36. 36.
    Overbergh L, Decallonne B, Waer M et al (2000) 1alpha, 25-dihydroxyvitamin-D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p 524–543). Diabetes 49:1301–1307PubMedCrossRefGoogle Scholar
  37. 37.
    Bhalla A, Amento E, Serog B, Glimcher L (1984) 1, 25-Dihydroxyvitamin-D3 inhibits antigen-induced T cell activation. J Immunol 133:1748–1754PubMedGoogle Scholar
  38. 38.
    Lemire J (1992) Immunomodulatory role of 1, 25-dihydroxyvitamin-D3. J Cell Biochem 49:26–31PubMedCrossRefGoogle Scholar
  39. 39.
    Lemire JM, Archer D, Beck L, Spiegelberg H (1995) Immunosuppressive actions of 1, 25-dihydroxyvitamin-D3: preferential inhibition of Th1 functions. J Nutr 125:1704S–1708SPubMedGoogle Scholar
  40. 40.
    Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B (2007) Vitamin D in rheumatoid arthritis. Autoimmun Rev 7:59–64PubMedCrossRefGoogle Scholar
  41. 41.
    Penna G, Amuchastegui S, Cossetti C et al (2006) Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin-D receptor agonist elocalcitol. J Immunol 177:8504–8511PubMedGoogle Scholar
  42. 42.
    Penna G, Adorini L (2000) 1α, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405–2411PubMedGoogle Scholar
  43. 43.
    Adorini L, Giarratana N, Penna G (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16:127–134PubMedCrossRefGoogle Scholar
  44. 44.
    Luciano A, Giuseppe P (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4:404–412CrossRefGoogle Scholar
  45. 45.
    Daniel C, Schlauch T, Zugel U, Steinmeyer A et al (2005) 22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities. Eur J Clin Invest 35:343–349PubMedCrossRefGoogle Scholar
  46. 46.
    Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y (2007) Anti-vitamin-D, vitamin-D in SLE: preliminary results. Ann NY Acad Sci 1109:550–557PubMedCrossRefGoogle Scholar
  47. 47.
    Ramos-Lopez E, Jansen T, Ivaskevicius V et al (2006) Protection from type 1 diabetes by vitamin-D receptor haplotypes. Ann NY Acad Sci 1079:327–334PubMedCrossRefGoogle Scholar
  48. 48.
    Rudko AA, Kondrateva EI, Iankina GN, Loshkova EV, Puzyrev VP (2008) Influence of polymorphism of immune defense modifier genes on celiac disease development and various clinical features of disease in Tomsk population. Mol Biol Mosk 42:42–49PubMedGoogle Scholar
  49. 49.
    San-Pedro JI, Bilbao JR, Perez de nanclares G, Vitoria JC, Martul P, Castano L (2005) Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus. Autoimmunity 38:439–444PubMedCrossRefGoogle Scholar
  50. 50.
    Bailey R, Cooper J, Zeitels L et al (2007) Association of the vitamin-D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56:2616–2621PubMedCrossRefGoogle Scholar
  51. 51.
    Huang C, Wu M, Wu J, Tsai F (2002) Association of vitamin-D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 11:31–34PubMedCrossRefGoogle Scholar
  52. 52.
    Shimada A, Kanazawa Y, Motohashi Y et al (2008) Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun 30:207–211PubMedCrossRefGoogle Scholar
  53. 53.
    Abe J, Nakamura K, Takita Y, Nakano T, Irie H, Nishii Y (1990) Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha, 25-dihydroxyvitamin-D3. J Nutr Sci Vitaminol 36:21–31PubMedCrossRefGoogle Scholar
  54. 54.
    Daniel C, Radeke H, Sartory N et al (2006) The new low calcemic vitamin-D analog 22-ene-25-oxa-vitamin-D prominently ameliorates Th1-mediated colitis in mice. J Pharmacol Exp Ther 319:622–631PubMedCrossRefGoogle Scholar
  55. 55.
    Cantorna M, Hayes C, DeLuca H (1996) 1, 25-Dihydroxyvitamin-D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93:7861–8764PubMedCrossRefGoogle Scholar
  56. 56.
    Cantorna M, Humpal-Winter J, DeLuca H (1999) Dietary calcium is a major factor in 1, 25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 129:1966–1971PubMedGoogle Scholar
  57. 57.
    Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R (1994) Prevention of autoimmune diabetes in NOD mice by 1, 25 dihydroxyvitamin-D3. Diabetologia 37:552–558PubMedCrossRefGoogle Scholar
  58. 58.
    Munger K, Zhang S, O'Reilly E et al (2004) Vitamin-D intake and incidence of multiple sclerosis. Neurology 62:60–65PubMedCrossRefGoogle Scholar
  59. 59.
    Goldberg P, Fleming M, Picard E (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin-D. Med Hypotheses 21:193–200PubMedCrossRefGoogle Scholar
  60. 60.
    Merlino L, Curtis J, Mikuls T et al (2004) Vitamin-D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50:72–77PubMedCrossRefGoogle Scholar
  61. 61.
    Birlea S, Costin G, Norris D (2008) Cellular and molecular mechanisms involved in the action of vitamin-D analogs targeting vitiligo depigmentation. Curr Drug Targets 9:345–359PubMedCrossRefGoogle Scholar
  62. 62.
    Holick M (2007) Vitamin D deficiency. N Engl J Med 357:266–281PubMedCrossRefGoogle Scholar
  63. 63.
    Correale J, Ysrraelit MC, Gaitan MI (2009) Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132:1146–1160PubMedCrossRefGoogle Scholar
  64. 64.
    Adorini L, Penna G (2009) Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb Exp Pharmacol 188:251–273PubMedCrossRefGoogle Scholar
  65. 65.
    Ginde AA, Liu MC, Camargo CA Jr (2009) Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 169:626–632PubMedCrossRefGoogle Scholar
  66. 66.
    Pignotti GAP, Genaro PS, Pinheiro MM, Szejnfeld VL, Martini LA (2009) Is a lower dose of vitamin D supplementation enough to increase 25(OH)D status in a sunny country? Eur J Nutr 49:277–283PubMedCrossRefGoogle Scholar
  67. 67.
    Mansbach JM, Ginde AA, Camargo CA Jr (2009) Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D? Pediatrics 124:1404–1410PubMedCrossRefGoogle Scholar
  68. 68.
    Gannage-Yared MH, Chemali R, Yaacoub N, Halaby G (2000) Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 15:1856–1862Google Scholar
  69. 69.
    Mishal AA (2001) Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporos Int 12:931–935PubMedCrossRefGoogle Scholar
  70. 70.
    Kimlin M, Harrison S, Nowak M, Moore M, Brodie A, Lang C (2007) Does a high UV environment ensure adequate vitamin D status? J Photochem Photobiol B 89:139–147PubMedCrossRefGoogle Scholar
  71. 71.
    Holick MF (2008) Deficiency of sunlight and vitamin D. BMJ 336:1318–1319PubMedCrossRefGoogle Scholar
  72. 72.
    Bischoff-Ferrari H (2009) Vitamin D: what is an adequate vitamin D level and how much supplementation is necessary? Best Pract Res Clin Rheumatol 23:789–795PubMedCrossRefGoogle Scholar
  73. 73.
    Mithal A, Wahl DA, Bonjour JP, Burckhardt P et al (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20:1807–1820PubMedCrossRefGoogle Scholar
  74. 74.
    Oren Y, Shapira Y, Agmon-Levin N, Kivity S, Zafrir Y, Altman A, Lerner A, Shoenfeld Y (2010) Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. IMAJ 12:2–7Google Scholar
  75. 75.
    Walters JR (2003) The role of the intestine in bone homeostasis. Eur J Gastroenterol Hepatol 15:845–849PubMedCrossRefGoogle Scholar
  76. 76.
    Bernstein CN, Leslie WD (2003) The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol 15:857–864PubMedCrossRefGoogle Scholar
  77. 77.
    Vestergaard P (2003) Bone loss associated with gastrointestinal disease; prevalence and pathogenesis. Eur J Gastroenterol Hepatol 15:851–856PubMedCrossRefGoogle Scholar
  78. 78.
    Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R (2005) Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 28:393–399CrossRefGoogle Scholar
  79. 79.
    Legroux-gerot I, Leloire O, Blanckaert F, Tonnel F et al (2009) Screening for celiac disease in patients with osteoporosis. Joint Bone Spine 76:162–165PubMedCrossRefGoogle Scholar
  80. 80.
    Stazi AV, Trecca A, Trinti B (2008) Osteoporosis in celiac disease and in endocrine and reproductive disorders. World J Gastroenterol 28:498–505CrossRefGoogle Scholar
  81. 81.
    Capriles VD, Martini LA, Areas JA (2009) Metabolic osteopathy in celiac disease: importance of gluten-free diet. Nutr Rev 67:599–606PubMedCrossRefGoogle Scholar
  82. 82.
    Hartman C, Hino B, Lerner A et al (2004) Bone quantitative ultrasound and bone mineral density in children with celiac disease. J Pediatr Gastrointerol Nutr 39:504–510CrossRefGoogle Scholar
  83. 83.
    Walker-Smith JA, Guandalini S, Schmitz J et al (1990) Revised criteria for the diagnosis of celiac disease. Report of the working group of European Society of Pediatric Gastroenterology and Nutrition. Arch Dis Child 65:909–911CrossRefGoogle Scholar
  84. 84.
    Levis S, Gomez A, Jimenez C et al (2005) Vitamin D deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab 90:1557–1562PubMedCrossRefGoogle Scholar
  85. 85.
    Saintonge S, Bang H, Gerber LM (2009) Implication of a new definition of vitamin D deficiency in a multiracial US adolescent population: the national health and nutrition examination survey III. Pediatrics 123:797–803PubMedCrossRefGoogle Scholar
  86. 86.
    Hirani V, Tull K, Ali A, Mindell J (2010) Urgent action needed to improve vitamin D status among older people in England! Age Ageing 39:62–68PubMedCrossRefGoogle Scholar
  87. 87.
    Lagunova Z, Porojnicu AC, Lindberg F et al (2009) The dependency of vitamin D status on body mass index, gender, age, and season. Anticancer Res 29:3713–3720PubMedGoogle Scholar
  88. 88.
    Kinsey L, Burden ST, Bannerman E (2008) A dietary survey to determine if patients with celiac disease are meeting current healthy eating guidelines and how their diet compared to that of the British general population. Eur J Clin Nutr 62:1333–1342PubMedCrossRefGoogle Scholar
  89. 89.
    Colston KW, Mackay AG, Finlayson C et al (1994) Localization of vitamin D receptor in normal human duodenum and in patients with coeliac disease. Gut 35:1219–1225PubMedCrossRefGoogle Scholar
  90. 90.
    Rossi TM, Kumar V, Lerner A, Heitlinger LA, Tucker N, Fisher J (1988) Relationship of endomysial antibodies to jejunal mucosa pathology: specificity towards both symptomatic and asymptomatic celiacs. J Pediatr Gastroenterol Nutr 7:858–863PubMedCrossRefGoogle Scholar
  91. 91.
    Yanbin D, Polloc N, Stallmann-Jorgensen IS et al (2010) Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics 125:1104–1111CrossRefGoogle Scholar
  92. 92.
    Toh SY, Zarshenas N, Jorgensen J (2009) Prevalence of nutrient deficiencies in bariatric patients. Nutrition 25:1150–1156PubMedCrossRefGoogle Scholar
  93. 93.
    Nilas L, Christiansen C (1987) Vitamin D deficiency after selective vagotomy. Acta Med Scand 221:303–306PubMedCrossRefGoogle Scholar
  94. 94.
    D’Elios MM, Amedel A, Benagiano M et al (2005) Helicobacter pylori, T cells, and cytokines: the “dangerous liaisons”. FEMS Immunol Med Microbiol 44:113–119PubMedCrossRefGoogle Scholar
  95. 95.
    Hosseini ME, Oghalaie A, Habibi G et al (2010) Molecular detection of host cytokine expression in Helicobacter pylori infected patients via semi-quantitative RT-PCR. Indian J Med Microbiol 28:40–44PubMedCrossRefGoogle Scholar
  96. 96.
    Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y et al (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9:709–715Google Scholar
  97. 97.
    Mimouni FB (2010) Vitamin D status in growing children: Should we routinely screen for vitamin D adequacy. J Pediatr Gastroenterol Nutr 51:S121–S122Google Scholar
  98. 98.
    Hill ID, Dirks MH, Liptak GS et al (2005) Guidelines for the diagnosis and treatment of celiac disease in children: recommendation of the North American society for pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr 40:1–19PubMedCrossRefGoogle Scholar
  99. 99.
    Kupper C (2005) Dietary guidelines and implementation for celiac disease. Gastroenterology 128:s121–s127PubMedCrossRefGoogle Scholar
  100. 100.
    Blazina S, Bratanic N, Campa AS, Blagus R, Orel R (2010) Bone mineral density and importance of strict gluten-free diet in children and adolescents with celiac disease. Bone 47:598–603PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Aaron Lerner
    • 1
    • 4
  • Yinon Shapira
    • 2
  • Nancy Agmon-Levin
    • 2
  • Avi Pacht
    • 1
  • Dana Ben-Ami Shor
    • 2
  • Hoyos Marcus López
    • 3
  • Maria Sanchez-Castanon
    • 3
  • Yehuda Shoenfeld
    • 2
  1. 1.Pediatric Gastroenterology and Nutrition Unit, Carmel Medical Center, B. Rappaport School of MedicineTechnion-Israel Institute of TechnologyHaifaIsrael
  2. 2.The Zabludowicz Center for Autoimmune Diseases and Department of Medicine B, Sheba Medical Center, Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael
  3. 3.Servicio Inmunología Hospital Universitario Marqués de ValdecillaSantanderSpain
  4. 4.Pediatric Gastroenterology and Nutrition Unit, Carmel Medical CenterHaifaIsrael

Personalised recommendations